Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 04, 2023

Tirzepatide 10 mg and 15 mg vs Semaglutide 2.4 mg for the Treatment of Obesity

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison
Diabetes Obes Metab 2023 Jun 21;[EPub Ahead of Print], CW le Roux, ER Hankosky, D Wang, R Malik, M Yu, A Hickey, H Kan, MC Bunck, A Stefanski, LE Garcia-Perez, S Wharton

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading